AKT1 and gastric cancer: Importantly, we investigated the therapeutic role of Rg3 in GPL treatment via inhibiting the glycolysis process through PI3K/AKT/mTOR pathway downregulation and miRNA-21 targeting and analyzed the effects of Rg3 to induce cell apoptosis in Atp4a−/− mice treated for gastric cancer cells.